Treatment Guidelines
- Vitiligo is a non-lethal, non-communicable, immune-mediated and generally progressive skin disease that creates milky white patches of irregular shape on the skin. A specific type of leukoderma, vitiligo is the most common form of pigmentary disor...
- On the outside, severe sunburn, physical skin damage, prolonged contact with certain chemicals containing: p-phenylenediamine (also known as para-phenylene diamine or PPD) para-tertiary butylphenol (PTBP) monobenzylether of hydroquinone (MBH)...
- While vitiligo is an incurable condition, it is manageable through various treatment options. These include FDA-approved and off-label medications, light therapy, microsurgery, and adjunctive therapies. The effectiveness of these treatments varies...
- Here are some of the vitiligo treatment protocols that must be further adjusted to suit a patient’s situation and local drug availability: If an adult patient just has a few, relatively stable spots, topical steroid – such as 0.1% betamethasone...
- Second-line therapies primarily focus on improving skin appearance with a combination of topical, systemic and UVB phototherapy treatments. Such treatment duration varies from 8 to 24 months of two- to trice-weekly treatments, with an average 65-7...
- Surgical options for vitiligo are divided into two main categories: tissue transplantation and cell transplantation. Both approaches have similar success rates, but they differ in procedure and complexity. The primary goal of these surgeries is to...
- In the dynamic field of dermatology, there is growing interest in experimental treatments for vitiligo. Experienced dermatologists often consider these novel approaches, either due to their unique availability in certain regions or because their p...
- There is no solid retrospective data on the symptomatic recurrence rate after a successful treatment. Available evidence suggests a high chance of over 50% recurrence rate within a 4-year period. Sometimes new lesions appear while patients are bus...
FAQOther Questions
- Does vitiligo increase the risk of skin cancer?
No, it does not. Despite common misconceptions, people with vitiligo are actually at a lower risk of developing skin cancer—including both nonmelanoma skin cancer (NMSC) and mal...
- What are risks of oral and topical corticosteroids?
Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...
- Which diseases most commonly accompany vitiligo?
Vitiligo is an autoimmune disease and is frequently associated with other autoimmune diseases, acccording to a 10-year study. The exact diseases that accompany vitiligo can vary...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.